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Summary
Although review papers on causal inference methods are now available, there is a
lack of introductory overviews onwhat they can render and on the guiding criteria for
choosing one particular method. This tutorial gives an overview in situations where
an exposure of interest is set at a chosen baseline (‘point exposure’) and the target out-
come arises at a later time point. We first phrase relevant causal questions and make
a case for being specific about the possible exposure levels involved and the popula-
tions for which the question is relevant. Using the potential outcomes framework, we
describe principled definitions of causal e ects and of estimation approaches classi-
fied according to whether they invoke the no unmeasured confounding assumption
(including outcome regression and propensity score-based methods) or an instru-
mental variable with added assumptions. We discuss challenges and potential pitfalls
and illustrate application using a ‘simulation learner’, that mimics the e ect of vari-
ous breastfeeding interventions on a child’s later development. This involves a typical
simulation component with generated exposure, covariate, and outcome data that
mimic those from an observational or randomised intervention study. The simula-
tion learner further generates various (linked) exposure types with a set of possible
values per observation unit, from which observed as well as potential outcome data
are generated. It thus provides true values of several causal e ects. R code for data
generation and analysis is available on www.ofcaus.org, where SAS and Stata code
for analysis is also provided.
KEYWORDS:
Causation; Instrumental variable; Inverse probability weighting; Matching; Potential outcomes; Propen-
sity score.
1 INTRODUCTION
The literature on causal inference methods and their applications is expanding at an extraordinary rate. In the field of health
research, this is fuelled by opportunities found in the rise of electronic health records and the revived aims of evidence-based
precision medicine. One wishes to learn from rich data sources how di erent exposure levels causally a ect expected outcomes
in specific population strata so as to inform treatment decisions. While an abundance of machine learning techniques can handle
electronic health records, they too need to integrate fundamental principles of causal inference to address causal questions.1
Neither the mere abundance of data nor the use of a more flexible model pave the road from association to causation.
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Experimental studies have the great advantage that treatment assignment is randomized. A simple comparison of outcomes on
di erent randomized arms then yields an intention-to-treat e ect as a robust causal e ect measure. However, non-experimental
or observational data remain necessary for several reasons. 1) Randomised controlled trials (RCTs) tend to be conducted in rather
selected populations, to reduce costs and for ethical reasons. 2) We may seek to learn about the e ect of treatments actually
received in these trials, beyond the pragmatic e ect of treatment assigned. This calls for an exploration of compliance with the
assignment and hence for follow-up exposure data, i.e. non-randomized components of treatment received. 3) In many situations
(treatment) decisions need to be taken also in the absence of RCT evidence 4) Awealth of patient data is being gathered in disease
registries and other electronic patient records; these often contain more variables, larger sample sizes and greater population
coverage than are typically available in an RCT setting. These needs and opportunities push scientists to seek causal answers in
observational settings with larger and less selective populations, with longer follow-up, and with a broader range of exposures
and outcome types (including adverse events).
Statistical causal inference has made great progress over the last quarter century, deriving new estimators for well-defined
estimands using new tools such as directed acyclic graphs (DAGs) and structural models for potential outcomes.2,3, 4
However, research papers – both theoretical and applied – tend to start from a question that is already formalised, and often
describe published conclusions in vague causal terms missing a clear specification of the target of estimation. Typically, when
this is specified, i.e. there is a well-defined estimand, a range of techniques can yield (asymptotically) unbiased answers under
a specific set of assumptions. Several overview papers and tutorials have been published in this field. They are mostly focused,
however, on the properties of one particular technique without addressing the topic in its generality. Yet in our experience, much
confusion still exists about what exactly is being estimated, for what purpose, by which technique, and under what plausible
assumptions. Here, we aim to start from the beginning, considering the most commonly defined causal estimands, the assump-
tions needed to interpret them meaningfully for various specifications of the exposure variable and the levels at which we might
intervene to achieve di erent outcomes. In this way, we o er guidance on understanding what questions can be answered using
various principled estimation approaches while invoking sensibly structured assumptions.
We illustrate concepts and techniques referring to a case study exemplified by simulated data, inspired by the Promotion of
Breastfeeding Intervention Trial (PROBIT),5 a large RCT in which mother-infants pairs across 31 Belarusian maternity hospitals
were randomised to receive either standard care or an o er to follow a breastfeeding encouragement programme. Aims of the
study were to investigate the e ect of the programme and breastfeeding on a child’s later development. We use simulated data
to examine weight achieved at age 3 months as the outcome of interest in relation to a set of exposures defined starting from
the intervention and several of its downstream factors. Our simulation goes beyond mimicking the ‘observed world’ by also
simulating for every study participant how di erent exposures strategies would lead to di erent potential responses. We call this
the simulation learner PROBITsim and refer to the setting as the Breastfeeding Encouragement Programme (BEP) example.
Source code for implementation is available on www.ofcaus.org.
Our aim here is to give practical statisticians a compact but principled and rigorous operational basis for applied causal
inference for the e ect of point (i.e. baseline) exposures in a prospective study.We build up concepts, terminology, and notation to
express the question of interest and define the targeted causal parameter. In section 2, we lay out the steps to take when conducting
this inference, referring to key elements of the data structure and various levels of possible exposure to treatment. Sections 3
presents the potential outcomes framework with underlying assumptions, and formalises causal e ects of interest. In section
4, we describe PROBITsim, our simulation learner. We then derive various estimation approaches under the no unmeasured
confounding assumption and under the instrumental variable assumption in section 5. We explain how the approaches can be
implemented for di erent types of exposures, and apply the methods on the simulation learner in section 6. We end with an
overview that highlights overlap and specificity of the methods as well as their performance in the context of PROBITsim, and
more generally. R code for data generation, R, SAS and STATA code for analysis and reporting, and slides that accompany this
material and apply the methods to a second case study can be found on www.ofcaus.org.
2 FROM SCIENTIFIC QUESTIONS TO CAUSAL PARAMETERS
Causal questions ask what would happen to outcome Y , had the exposure A been di erent from what is observed. To formalise
this, we will use the concept of potential outcomes6,7 that captures the thought process of setting the treatment to values a À A,
a set of possible treatment values, without changing any pre-existing covariates or characteristics of the individual. Let Ya(a) be
the potential outcome that would occur if the exposure were set to take the value a, with notation a(a) indicating the action of
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setting A to a. In what follows we will refer to A as either an ‘exposure’ or a ‘treatment’ interchangeably. Since individual level
causal e ects can never be observed, we focus on expected causal contrasts in certain populations. In the BEP example there are
several linked definitions of treatment; these include ‘o ering a BEP’, ‘following a BEP’, ‘starting breastfeeding’ or ‘following
breastfeeding for 3 full months’. Each of them may require a decision of switching the treatment on or o . Ideally this decision
is informed by what outcome to expect following either choice.
It is important that causal contrasts should reflect the research context. Hence in this example one could be interested in
evaluating the e ectiveness of the programme for the total population or in certain sub-populations. However, for some sub-
populations the intervention may not be suitable and thus assessing causal e ects in such sub-populations would not be useful.
Consider the following question: “Does a breastfeeding intervention, such as the one implemented in the PROBIT trial,
increase babies weight at three months?” Despite its simplicity, empirical evaluation of this question involves its translation
into meaningful quantities to be estimated. This requires several intermediate steps:
1. Define the treatment and its relevant levels/values corresponding to the scientific question of the study.
2. Define the outcome that corresponds to the scientific questions under study.
3. Define the population(s) of interest.
4. Formalise the potential outcomes, one for each level of the treatment that the study population could have possibly
experienced.
5. Specify the target causal e ect in terms of a parameter, i.e. the estimand, as a (summary) contrast between the potential
outcome distributions.
6. State the assumptions validating the causal e ect estimation from the available data.
7. Estimate the target causal e ect.
8. Evaluate the validity of the assumptions and perform sensitivity analyses as needed.
Explicitely formulating the decision problem one aims to solve or the hypothetical target trial one would ideally like to conduct8
may guide the steps outlined above. In the following we expand on steps 1-5 before introducing the simulation learner in Section
3 and discussing steps 6-8 in Section 4.
2.1 Treatments
Opinions in the causal inference literature di er on how broad the definition of treatment may be. Some say that the treatment
should be manipulable, like giving a drug or providing a breastfeeding encouragement programme.9 Here, we take a more liberal
position which would also include for example genetic factors or even (biological) sex as treatments. Whichever the philosophy,
considered levels of the treatments to be compared need a clear definition, as discussed below.10
Treatment definitions are by necessity driven by the context in which the study is conducted and the available data. The causal
target may thus di er for a policy implementation or a new drug registration, for instance, or whether the data are from an RCT
or administrative data. In the BEP example we may wish to define the causal e ect of a breastfeeding intervention on the babies’
weight at three months. There are several alternative specifications of a ‘breastfeeding treatment’ possible. Below we list a few
which are interconnected and represent di erent types of treatment decisions:
• A1 : (randomised) treatment prescription: e.g. an encouragement programme was o ered to pregnant women.
• A2 : uptake of the intervention: e.g. the woman participated in the programme (when o ered).
• A3 : uptake of the target of intervention: e.g. the mother started breastfeeding.
• A4 : completion of the target of intervention: e.g. the mother started breastfeeding and continued for three months.
Each of these treatment definitions Ak, k = 1, ..., 4, refers to a particular breastfeeding event taking place (or not). A public
health authority will be more interested in A1 because it can only decide to o er the BEP or not; an individual mothers interste
will be in the e ect ofA2,A3 andA4 because she decides to participate in the programme and to start and maintain breastfeeding.
For any one, several possible causal contrasts may be of interest and are estimable. See Section 2.6.
It is worth noting that these various definitions are not all clear-cut. For example, while A4 = 1 may be most specific in what
it indicates, A4 = 0 represents a whole range of durations of breastfeeding: from none to ‘almost 3 months’. In the same vein,
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A3 = 1 represents a range of breastfeeding durations that follow initiation, against A3 = 0 which implies no breastfeeding at
all. The variation in underlying levels of treatment could be seen as multiple versions of the treatment; we consider this topic
further in Section 3.2.
Intervening at a certain stage in the ‘exposure chain’ likely a ects downstream exposure levels, as reflected in Figure 1. This
is the set-up we have used to generate the simulation learner dataset (see Section 3), with the BEP being only available to those
randomized, and where uptake of the programme increases the probability ofA3 = 1 and, importantly, also increases breastfeed-
ing duration among women who initiate breastfeeding. There are of course many further aspects of the breastfeeding process
that could be considered when defining exposures that are downstream from an initial randomized intervention, e.g. maternal
diet, the timing and frequency of breastfeeding, exclusive versus predominant breastfeeding, and so on, however for didactic
purposes, we shall omit such considerations.
2.2 Outcomes
Similar to the definition of the treatment, it is important to carefully define the outcome Y . In the BEP example, the outcome
of interest could be the infant’s weight at three months, or the increment between birth weight and weight at three months or
whether the infant is above a certain weight at 3 months. Typically, the distribution of both the absolute and relative weight are
of interest: a BEP may well increase mean weight at 3 months by 200 grams but also increase the number of overweight infants.
Clarity of which outcome definition corresponds to the question of interest is therefore crucial.
2.3 Populations
A causal e ect will in most cases vary between populations due to e ect modification. It is then important to identify and
describe the population to whom a stated e ect pertains. Often one is interested in the causal e ects in several sub-populations.
Researchers and policy-makers might want to study if the breastfeeding intervention is substantially more e ective for infants of
less educated women who may be at highest risk of being born low weight. They could also wonder about the e ect of treatment
in the subpopulation of those who are actually exposed (the ‘treated’, as discussed above).
In the next section we will develop causal e ects for the di erent sub-populations. In most settings we want to consider
populations of individuals who have the possibility of receiving all treatment levels of interest. This condition is referred to as
the positivity assumption.11 It could be violated, for example, if the target population included women for whom breastfeeding
is precluded (because of pre-existing or pregnancy-related conditions). Studying the e ect of breastfeeding in the subpopulation
of infants whose mothers cannot breastfeed (or indeed a larger population that includes this subgroup) may be impossible due
to missing information – and indeed irrelevant.
2.4 Potential outcomes
As stated above, a potential outcome Ya(a) is the outcomewewould observe if an exposure were set at a certain level a, where a(a)
indicates the action of settingA to a. This notion needs some additional considerations linking it to the treatments and outcomes
definitions given above. Specifically there are two commonly invoked assumptions that help achieve this: no interference and
causal consistency.
No interference
No interference means that the impact of treatment on the outcome of individual i is not altered by other individuals being
exposed or not. At first sight this is likely justified in our setting: one baby’s weight typically does not change because another
baby is being breastfed. In resource poor or closely confined settings this could, however, be challenged. For instance, interference
would happen when a child is a ected by the consequences of a reduced immune system of other children who were not breastfed
and hence became more susceptible to infectious diseases which may impact their weight at three months.
When the assumption of no interference is not met, the potential outcome definition becomesmuchmore complex and involves
the treatment assigned to other individuals.12 For example, if there were interference among infants living in the same household,
the potential outcome of infant i would be defined not as Ya(a) but as Yai(a),ai1 (a<),…, aiKi (a†), where infants i1 to iKi belong to thesame household as infant i and their breastfeeding status is set to take values (a<,… , a†).
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Causal consistency
The assumption of causal consistency relates the observed outcome to the potential outcomes. Consistency (at an individual
level) means that Ya(a) = Y when A = a, hence assuming consistency implies that the observed outcome in our data is the same
as the potential outcome that would be realised in response to setting the treatment to the level of the exposure that was observed.
This directly a ect our interpretation of the estimated causal e ect for the study population. It will also a ect transportability
to new settings in ways that may be hard to predict.
In practice this implies that the mode of receiving as opposed to choosing treatment level A = a per se has no impact on
outcome. This may not be the case for many real life settings. For example ‘starting breastfeeding’ (A3 = 1) potentially has
multiple versions as some mothers who initiate breastfeeding may continue to do so for at least 3 months, while others may
discontinue sooner. Also, breastfeeding may be exclusive or supplemented, breast milk may be fed at the breast or with a bottle,
and so on. Hence it is to be expected that setting A3 to be 1 may translate into di erent durations and types of breastfeeding,
and thus may not lead to the same infant weight at 3 months as when starting breastfeeding is a choice. More generally, it is
typically the case that a treatment can come in many variations at some level of resolution. To achieve consistency then a more
precise definition of treatment is required, so that observing or setting it is more likely to generate comparable e ects.
These observations relate to the importance of a well-defined exposure13 and the need to be as precise as the data allow
us in our definition of treatment.14 Some authors have criticised the restriction imposed by this assumption (and hence by the
potential outcomes approach to causal inference10). Being aware of the possibility of multiple versions of treatment should not
deter us from pursuing the most relevant definition of treatment: instead it should lead us to greater precision and transparency
in formulating the causal question and its transportability.
Note also that the assumption of consistency may be relaxed by rephrasing it at the distributional level (possibly conditional
on baseline covariates), in the sense that consistency would concern for example the equality of the mean observed outcome
of those with observed values A = a and the mean potential outcome had their treatment been set to a. Following this broader
definition, any causal interpretation would be applicable only to settings where the distribution of the di erent versions of
treatment equaled that in the analyzed sample.
2.5 Nested potential outcomes
The treatments considered here belong to a chain: whenA1 is set, it has consequences for the “worlds” whereA2,A3 andA4 act.
Equivalently, when A3 is set at a subsequent baseline time, where breastfeeding starts, A1,A2 become baseline covariates with
consequences for the worlds that follow. Although this paper does not enter into the full framework of estimation for dynamic
treatment strategies, we can benefit from additional definitions of potential outcomes that recognise the nested nature of the
interventions.
Below we define worlds where setting A2 and A3 occurs under alternative scenarios that depend on how A1 was set (and, for
A3, how A1 and or A2was set). These will be useful for the discussion in 2.6.
1. In the world where BEP is on o er to all (i.e. when a1(1) is set for everyone in the population), the potential outcomes of
participating or not participating in the BEP are defined as Ya1(1),a2(1) and Ya1(1),a2(0). Similarly in the world where BEP isnot o ered, we may consider the potential outcome of not participating in the BEP defined as Ya1(0),a2(0). In our examplewe assumed that the programme was only available to the intervention group (i.e. Ya1(0),a2(1) is not defined), and that theintervention would only a ect outcome if the programme was actually followed (i.e. Ya1(1),a2(0) = Ya1(0),a2(0)). (In othersettings it is conceivable that the mere invitation to BEP, comes with advice that may have a direct impact on outcome
under a2(0)).
2. Setting a2(1), here implies that A1 is set to 1; setting a2(0) can happen independently of how A1 is set. The corresponding
potential outcomes are denoted by Ya2(1)(= Ya1(1),a2(1)) and Ya2(0).
3. Similarly, when interest is in the causal e ect of A3, the potential outcomes of starting or not starting breastfeeding in the
world with BEP on o er are Ya1(1),a3(1) and Ya1(1),a3(0), and in the world without BEP, they are Ya1(0),a3(1) and Ya1(0),a3(0).We deliberately omitted setting/fixing the possible a2 level here, because we let it follow the natural course after setting
a1(1), meaning that women may or may not choose to follow the BEP, after receiving the o er. The e ect of breastfeeding
in the world where the BEP is o ered, may di er from the e ect when the BEP is not available, as the BEP may not only
a ect the probability to start breastfeeding, but also the duration of breastfeeding for those who start.
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4. One could be tempted to evaluate Ya3(1) in the study context, ignoring A1 and e ectively averaging over the observed A1,distribution which follows from equal randomization. Such random BEP o er is however no intended real world future
scenario and hence that particular average e ect measure is of no direct relevance to any realistic scenario.
5. In the world where all women follow the programme (i.e. a2(1) is set, implying also a1(1) as we assume BEP cannot be
followed unless it is o ered), the potential outcomes of starting breastfeeding or not are Ya2(1),a3(1) and Ya2(1),a3(0).
2.6 Causal parameters
The next step is to contrast potential outcomes under di erent settings of exposure variables.We do so by defining an estimand in
a well-defined (sub)population. Individual causal e ects cannot be computed since each individual can only be assigned to one
treatment at a time since via consistency one and only one potential outcome can be observed. However, population summary
measures can be estimated (under additional assumptions to be discussed below) for di erent groups, such as the total population
or the sub-population of treated (or untreated) individuals. Also, causal e ects can be defined on di erent scales. In this paper
we focus on the mean di erence as the contrast of interest.
Table 1 describes a selection of causal parameters for exposures A1 and A2. The first estimand for A1 listed in the table is
the average treatment e ect in the population (ATE1) and corresponds to the question “What would the average infant weight
at 3 months be had all mothers been o ered the BEP, versus the average infant weight had the mothers not been o ered the
programme?”. It is defined as ATE1 = E[Ya1(1)]*E[Ya1(0)], which is equal to the intention to treat e ect(ITT) of the randomisedtrial.
There are several possible contrasts involving uptake of the interventionA2. We could target the causal question “What would
the average infant weight at 3 months be had all mothers attended the BEP, versus the average infant weight had none of the
mothers attended the programme?” over the whole infant population, leading to ATE2 = E[Ya2(1)] * E[Ya2(0)]. We might alsoconsider this e ect only within the population of women who chose to accept the o er and did attend the BEP. The latter would
be the ATT. Because in our example the BEP is only available to those who are o ered it, the treated population are those with
A2 = 1 and A1 = 1; see Table 1 . The e ect in the population, ATE2 would be of overall interest to the developers of the BEP,
as would the tratment e ect in the non treated ATNT2, because the latter would quantify the gain to be expected from a more
convincing promotion campaign for the current programme with larger attendance, i.e. a greater P (A2 = 1A1 = 1). In contrast
ATT2 might be of greater interests to mothers following BEP, as this would provide a measure of the expected benefit from their
own uptake of the BEP o er.
Furthermore, causal e ects may be heterogeneous across observable strata, for instance if the breastfeeding treatment has
di erent causal e ects depending on the education level of the mother. Thus causal e ects specific to baseline subgroups would
be of interest, e.g. the average causal e ect among those with low education and compare it to the average causal e ect among
those with high education. We can also define a causal e ect conditional on multiple characteristics such as the expected causal
e ect of the programme in the group of 30 year old smoking mothers with a child born by caesarian section.
3 THE SIMULATION LEARNER
To illustrate concepts and support our learning, we generated data informed by a real investigation but enriched by the generation
of potential outcome data in addition to ‘observed’ data. We follow Wallace et al.15 in simulating data to mimic the results of
the Promotion of Breastfeeding Intervention Trial5 (PROBIT). Mother-infant pairs were randomised to receive either standard
care or a breastfeeding encouragement intervention. In these simulations we are focussing on weight achieved at age 3 months,
thus the study population consists of babies who survive the first three months.
3.1 Generating the variables
Figure 1 outlines the main relationships among the simulated variables. The baseline variables L1 were: mother’s age, location
of living (urban versus rural and western versus eastern region), level of education (low, intermediate, high), maternal history
of allergy, and smoking during pregnancy. The variables related to the infant’s birth L2 were: sex of child, birth weight, and
birth by caesarian section. Thus, L1 are confounders of the relationship between A2 and Y , and (L1,L2) are confounders of
the relationship between A3 and Y . The distribution of these variables was made to resemble that of the PROBIT study and the
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sample size n was set to 17,044, as in that study. Details of the data generation process can be found in Appendix 1 and in the
material available at www.ofcaus.org; an overview is given below.
The o er of the programme (A1) was assigned randomly, but the uptake of programme (A2), starting breastfeeding (A3),
and the duration of breastfeeding (A4) were all a ected by variables at baseline (L1) or at birth (L2), with their union denoted
by the vector L. We made the simplifying assumptions that L2 were una ected by the programme o er, that the programme
was only available to women in the intervention group, and that the intervention would only a ect outcome if the programme
was actually followed. The odds of following the programme after receiving an o er was assumed to depend on maternal age,
education and smoking during pregnancy, such that older and more highly educated women had a higher probability of following
the programme, while smokers were less likely to do so.
Following the programme, i.e. A2 = 1 was set to influence weight at 3 months in two ways: it increased the probability of
starting breastfeeding, and increased the duration of breastfeeding if started. Older and more highly educated women and women
who did not smoke during pregnancy were more likely to start breastfeeding, while having a child with lower birth weight or
a baby girl decreased the probability of starting breastfeeding. The uptake of the program, higher age, higher education, not
smoking, a higher birth weight, and maternal allergies were set to increase the total duration of breastfeeding, while delivery by
caesarian or a having baby boy to lower it.
The outcome (weight at 3 months) was set to be a ected by the duration of breastfeeding and by the baseline and birth
variables, some of which (smoking, education and birth weight) also modified the e ect of breastfeeding.
For each woman in the simulated dataset, we observed realised values ofA1,A2,A3 andA4 and of the weight of the child after
3 months. In addition several potential outcomes were generated representing the potential weight at 3 months of the child under
di erent interventions on A1, A2, A3 and A4. This means that in our dataset, for each woman the potential weight of her child at
3 months is known under di erent scenarios: if she had received the o er for the BEP, if she had not received the o er, if she had
followed the programme, if she had or had not started breastfeeding and if she had continued breastfeeding for 3 months. Our
simulations generated correlated potential outcomes, but the causal parameters introduced so far are not a ected by this. We see
this as an advantage since there is an intrinsic lack of information on the joint distribution of the potential outcomes in observed
data. Table 2 gives the expected value of the di erent potential outcomes overall and in specific strata (subpopulations). These
values were obtained from a very large simulated dataset of 5 million observations and are here considered to represent the truth.
3.2 Di erent causal contrasts
From Table 2 we can derive several true causal contrasts. For example the average treatment e ect (ATE) of the BEP o er
is ATE1 = E[Ya1(1)] * E[Ya1(0)] = 6115 * 6017 = 98 grams. This e ect may be of interest to policy makers as it isthe overall mean change in infant weight at 3 months due to inviting expectant women to attend the BEP. Comparing the
scenario where everyone actually receives the o er and follows the BEP with no programme, the expected weight gain is
ATE2 = E[Ya2(1)] * E[Ya2(0)) = 165 grams. Among women who actually follow the programme (the treated), the e ect ofBEP uptake is ATT2 = E[Ya2(1)A2 = 1]*E[Ya2(0)A2 = 1]= 153 grams. The e ect of participating in the BEP among womenwho have the opportunity to follow it but opt not to, is ATNT2 = E[Ya2(1)A2 = 0,A1 = 1] * E[Ya2(0)A2 = 0,A1 = 1]= 185grams. ATNT2 is larger than ATT2 because women who would benefit most from the BEP were, in our simulated dataset, less
inclined to follow it.
In this tutorial, we are treating A1,A2,A3 and A4 as point exposures, i.e. as exposures to be examined separately, with any
previous exposures in the chain treated as background variables. In other words, for each targeted treatment, we consider the
time point at which it is implemented. We then ask about the impact of setting this treatment to a given value, conditional on
background information. In the setting of our study: when A3, the decision to start breastfeeding is implemented, the values
of A1 and A2 are already known and the baby has been born. The set of information carried by A1 and A2 could be treated as
baseline information, like L, conditional on which the e ect of starting breastfeeding is measured.
Alternatively, we could consider the joint impact of multiple interventions. Using the nested potential outcomes notation
introduced in section 2.5, we could address the question “What would the average infant weight at 3 months be had all mothers
started breastfeeding versus the average infant weight had they not started at all?” under di erent worlds where A1 and A2
are set to take di erent values. In the world without BEP, the answer would be ATE3,a1(0) = E[Ya1(0),a3(1)] * E[Ya1(0),a3(0)] =387 grams. In the world where the BEP is o ered, the gain in weight at 3 months would be substantially higher: ATE3,a1(1) =
E[Ya1(1),a3(1)] * E[Ya1(1),a3(0)] = 422 grams. The weight gain in the world where everyone followed the programme wouldbe ATE3,a2(1) = Ya2(1),a3(1) * Ya2(1),a3(0) = 450 grams. This is the largest e ect because, in the simulation, BEP increases the
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mean duration of breastfeeding. In general there are greater average potential outcomes with increased intensity of the joint
interventions.
The average treatment e ect in the treated (with respect to A3) also di ers between randomisation worlds because more
women among those randomised to receive the BEP will start breastfeeding than in the control group. The e ect of breastfeeding
in those who started breastfeeding and are in the intervention arm (i.e. A1 = 1) is equal to ATT3,a1(1) = E[Ya1(1),a3(1)A3 =
1,A1 = 1] * E[Ya1(1),a3(0)A3 = 1,A1 = 1] = 421 grams, and the e ect of breastfeeding in those who started breastfeeding butare in the control arm (i.e. A1 = 0) is ATT3,a1(0) = 381 grams. The average e ect of breastfeeding in those who did not startbreastfeeding is ATNT3,a1(1) = 424 gram when the programme is available and ATNT3,a1(0) = 393 grams when not.We could also ask the question “What would the average infant weight at 3 months be, had all mothers breastfeed for 3 months
versus the average infant weight had they not started at all?” As noted before, setting A4 = 0 will include a very heterogeneous
set of breastfeeding behaviours, as well as not breastfeeding at all. A more refined question would restrict the comparison to a
setting where there is no breastfeeding at all, i.e. E[Ya4(1)] * E[Ya3(0)] = 6351 * 5827 = 524 grams.When implementing an intervention, it is of interest to identify those subgroups for which the intervention is most beneficial.
Table 2 for example, shows that the infants of mothers in the lowest stratum of education would gain more than those of mothers
in the highest, both when the intervention is o ering the programme E[Ya1(1)L = low] * E[Ya1(0)L = low] = 110 gramsand when the intervention is following the programme E[Ya2(1)L = low] * E[Ya1(0)L = low] = 214 grams, as opposed to 66grams and 85 grams for women in the highest stratum of education.
Some of the causal e ects described above are not realistic. For example, the largest causal contrast is the expected weight
gain when every infant is breastfed for the full 3 months versus the expected weight gain when no one is breastfed (524 grams
above). However not all women can or wish to start breastfeeding (nor would all women willingly refrain from it). As alluded
to in the discussion of positivity in Section 2.3, a woman who is very ill at the end of pregnancy may not have the option of
breastfeeding her baby because of toxicity of prescribed medication or ill-health. It follows that considering the intervention
where every woman continues breastfeeding for the full 3 months is even less realistic. It is important to define the causal
question precisely in a pertinent population before turning to estimation.
4 PRINCIPLED ESTIMATION APPROACHES
The estimation approaches discussed here rely on further assumptions in addition to those outlined in section 2.4. These can
be classified according to whether or not they invoke the no unmeasured confounding (NUC) assumption which states that
the received treatment is independent of the potential outcomes, given covariates L. Formally, the NUC assumption states:
(Ya(0)) ⌅ AL and (Ya(1)) ⌅ AL, where, hereafter A denotes a binary exposure. In other words, the assumptions states that a
su cient set of variablesL that confound the exposure/outcome relationship have beenmeasured and are available to the analyst.
The estimation approaches that rely on the NUC assumption include standard outcome regression and propensity score (PS)
based methods such as PS stratification, regression, matching, and inverse probability weighting. These are reviewed below.
Alternatively, if an instrumental variable (IV) is available, IV methods can be used by also invoking additional assumptions in
place of NUC. IV definitions an assumptions are described in Section 4.2.
4.1 Methods based on the No Unmeasured Confounders assumption
When a su cient set of confounders L is measured, the causal e ect of treatment can be estimated by comparing observed
outcomes between the treated and untreated people with identical values forL. Such direct control forLmay be done in di erent
ways: by regression or stratification or matching. We discuss these approaches in the next subsections.
Before proceeding with the analysis one should examine how treatment groups di er in their population mix – that is, examine
the imbalance in covariates between treatment groups. This information can then be summarised in the propensity score.
The propensity score (PS) is the probability of being treated conditional on the covariates, e(L) = P (A = 1 › L).16 The
PS is an important function of the covariates that reduces the (possibly high dimensional) vector L into a scalar containing
all information that is relevant for the treatment assignment in relation to the outcome. This property is called the balancing
property, meaning that the covariate distributions of the treated and non-treated are the same when conditioning on the PS.
Intuitively, the role of the PS can be thought of as one of restoring balance between treated and untreated groups. For example,
if we were to compare all treated subjects with untreated subjects who all had the same value of the PS, the distribution of the
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covariates L would be the same, much like in a randomized trial. However unlike in a randomized trial, balance is not achieved
between the treated and untreated groups for any covariates that were not included in the PS. The balancing property implies that
all relevant confounding information in L is contained in e(L), so that if (Ya(0), Ya(1)) ⌅ AL, then also (Ya(0), Ya(1)) ⌅ Ae(L).
This implies that e(L) can be used instead of the full vector L.
The PS is estimated from the data, usually by fitting a parametric (e.g. logistic regression) model for the probability of being
treated given the confounding variables, although a variety of other approaches can be employed including tree-based classi-
fication.17 However derived, the adequacy of the estimated PS, Çe(L), as a balancing summary of the confounder distributions
across treatment groups must be evaluated18 by checking whether L ⌅ A › Çe(L)). While balance of the joint distribution of
the confounders L is required, in practice balance is often assessed for each confounder L À L separately by comparing stan-
dardized mean di erences, variance ratios, and other distributional statistics and plots such as empirical cumulative distribution
plots, between the treated and untreated groups after weighting, stratification, or matching by the estimated propensity score.19
We illustrate some of these checks in Appendix 2. To date, variable selection for propensity score modelling is done largely
on a trial and error basis, beginning with a model thought to contain all relevant confounders and adding higher order terms
(polynomials, interactions) if balance appears not to have been achieved.
The propensity score can also be used to examine the positivity assumption by checking for overlap of the propensity score
distribution of those who are treated and those who are not. For this reason, automatic variable selection approaches (e.g. step-
wise) or prediction-based measures of fit (e.g. C-statistic), which seek best prediction of treatment allocation when specifying
the PS model, may not provide the best balance for the confounders and favour variables that are strongly predictive of the
treatment, even if they are only weakly or not at all predictive of the outcome.
4.1.1 Outcome regression
Perhaps the simplest and most familiar form of causal estimation is outcome regression. In this approach, a model is posited
for the outcome as a function of the exposure and the covariates. For example, for a continuous outcome the linear regression
model of the form
E[Y A,L] =  0 +  1A +  ®2f (L,A)
where  2 is a vector of parameters and f (L,A) is a (vector) function of L and A representing, for example, the main e ect of
the covariates L and interactions between covariates and A. Ordinary least squares can be used to estimate the parameters of
the outcome linear regression model.
Assuming no interference, consistency and NUC,  1 is interpreted as the causal e ect of A in the reference categories of L
(i.e. where L = 0 if f (L,A)=0 when L = 0). This is a conditional causal e ect.
To estimate causal parameters such as those shown in Table 1 , the additional step of marginalizing over the distribution of
L is needed. For example, assuming that the model below is correctly specified
E[Y A,L] =  0 +  1A +  ®2L +  ®3LA
we identify the ATE for A as follows:
ATE = E{E[Ya(1)L]} * E{E[Ya(0)L]}
= E{E[Ya(1)A = 1,L]} * E{E[Ya(0)A = 0,L]}
= E{E[Y A = 1,L]} * E{E[Y A = 0,L]}
= ( 0 +  1 +  ®2E[L] +  
®
3E[L]) * ( 0 +  
®
2E[L])
=  1 +  ®3E[L],
where the second equality follows from the NUC assumption, the third from the consistency assumption and the fourth from
the assumption of correct specification of the outcome model. This estimand can be estimated by Ç 1 + Ç ®3n*1
≥n
i=1(li), where nis the sample size. When there are no treatment-covariate interactions (i.e.  3 is a vector of zeroes), then the ATE equals  1 and
its standard error can be taken directly from the fitted model that does not include any interactions. Otherwise, a standard error
accounting for the correlation between  1 and  3 as well as estimation of E[L] must be computed either analytically or via a
bootstrap procedure.
A similar approach can be taken to estimate the ATT (or the ATNT). The ATT, for instance, can be computed noting that
ATT = E{E[Ya(1)A = 1,L]} * E{E[Ya(0)A = 1,L]. Letting IA=1 denote the indices i of those exposed subjects and
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#IA=1 = ≥ni=1 ai denote the number of exposed individuals (the cardinality of IA=1), the ATT can be estimated using theoutcome regression coe cient estimates by
£ATT = (#IA=1)*1 …
iÀIA=1
( Ç 1 + Ç 
®
3li).
For binary and other categorical outcomes other appropriate outcome models can be used such as the logistic regression model.
This model will yield fitted values of E[Y A = 1,L] and E[Y A = 1,L] for all individuals which can then be averaged over
the appropriate population.
Concerns about model mis-specification may be reduced by using a more flexible model for the outcome. For example, we
may consider transformations of L such as splines to specify f (L,A), leading to a less parametric model which, however,
requires estimation of a greater number of parameters. An additional concern, is the possibility that a chosen outcome model
leads to extrapolations outside of the data cloud (in other words, to lack of positivity). Users should therefore be aware of this
and adopt methods discussed above to assess whether lack of positivity is an issue.
When an appropriate propensity score has been estimated such that it provides the desired balance, outcome regression can
also be performed with the generic function f (L,A) being replaced by Çe(L), assuming no interactions between L and A:
E[Y A,L] =  0 +  1A +  2 Çe(L).
This approach is known simply as propensity score regression with the ATE and ATT then estimated via standard regression
followed by averaging over the PS as opposed to L, much as in Section 4.1.1. It can be shown that for the linear outcome model
the propensity score regression estimators for the ATE and ATT are consistent under correct specification of the propensity
score, even if the outcome model is mis-specified, provided the treatment e ect is constant across e(L).20
4.1.2 Stratification and matching
Stratification can be used to estimate the ATE by taking the weighted sum of the di erences of sample means across strata, where
strata may be defined by ranges of the propensity score (fifths – i.e. using quintiles – is a common choice,21 for large sample sizes
increasing the number of strata will reduce the residual bias within strata)). The same approach could be used by stratification
by the covariates L, although this may be more challenging than stratifying or matching on the PS if L is not low-dimensional.
Let nj denote the number of individuals in stratum j = 1, ..., J . Finally, let Ç aj denote the sample average of Y for those with
treatment level a in the j-th stratum. Then the stratification-based estimator of the ATE is given by
J…
j=1
0nj
n
1
[ Ç 1j * Ç 0j].
This approach will work if there is reasonable balance of values of confounders in each of the defined strata. If not, one can
regress the outcome on confounders within strata and use the stratum-specific mean predicted value instead.22 Standard errors
for stratification-based estimators often rely on simplifying assumptions; again, bootstrap may be used as an alternative. The
ATT (and ATNT) can similarly be estimated by replacing the ratio nt_n with a ratio of the stratum proportion of the treated
(untreated) population.
Matching is similar in spirit to stratification, but taken to the finest strata: the individual level. For each individual i in the
sample, we selectM g 1 individuals, i®, who are matched to i based on some matching criterion and matching method. Then
the estimators of the ATE and ATT are, respectively,
n*1
n…
i=1
(2Ai * 1)
H
Yi *M*1
…
i®
Yi®
I
and (#IA=1)*1 …
iÀIA=1
H
Yi *M*1
…
i®
Yi®
I
,
where i® runs over the setMi of individuals matched to i.
In practice, the following algorithm should be followed:
1. Choose a matching criterion, Ci,i® such as nearest neighbour, the Mahalanobis distance, or vector norm, and implement a
matching method given the criterion. The criterion may be applied toL or to a summary such as the propensity score Çe(L).
2. Evaluate the quality of the matched sample by carrying out balancing checks described below.
3. If balance is not satisfactory, return to step 1.
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There are several factors to consider in a matched analysis, such as the number of matches per individual,M ; whether to match
with or without replacement; if matching without replacement, whether to use greedy matching or the more computationally
intensive optimal matching. A discussion of the relative merits and the impact of these choices on bias and variance can be
found in a review by Stuart.23 If balance remains unsatisfactory or to increase robustness, outcome regression as described in
Section 4.1.1 can be performed within the matched sample.
Several standard softwares include packages that implement matching and, in some cases, covariate balance checks. Note that
the bootstrap should not be used to compute standard errors following matching, and that suitable standard errors depend on
how the matching was carried out (e.g. whether with replacement or not).24
4.1.3 Inverse probability weighting
The idea behind inverse weighting is to construct a pseudo-sample in which there are no imbalances on measured covariates
between the treatment groups. While IPW can be used for treatments measured only at baseline, its strength is with time-varying
treatments. Let Wi be the inverse of the probability of the received treatment, defined as Wi = P (Ai = aiLi)*1 = e(L)*1.
Assuming no interference, consistency, NUC, and correct specification of the PS model, the average potential outcome if the
whole population were treated can, under causal consistency, be shown to equal
E
⌅
WiAiYi
⇧ (1)
An alternative definition of the weights, denoted stabilised weight, isWi = P (Ai = ai)P (Ai = aiLi)*1 and is often preferred
as it follows naturally from the theoretical derivation of IPW estimators25 and for time varying exposures typically leads to less
extreme values and more stable estimates.3 In practice, an estimated propensity score is used in place of P (Ai = 1L) and
P (Ai = 1) is replaced by a simple sample average before an empirical average is taken:
öE[Ya(1)] = n*1
n…
i=1
wiaiyi, (2)
where wi are such estimates ofWi. If there are many people with a given set of characteristics li who are treated, but few with
this characteristic who are not treated, then P (Ai = 1Li = li) will be ‘large’ and its inverse ‘small’ so these treated individuals
will be downweighted in the sample.
Similarly, an estimate of the average potential outcome if the whole population were set to be untreated is
öE[Ya(0)] = n*1
n…
i=1
wi(1 * ai)yi. (3)
As before, if there are many people with a given set of characteristics who are treated, but few who are not treated, then P (Ai =
0L = li) will be ‘small’ and its inverse ‘large’ so that these people are upweighted. This approach is well-known in the survey
sampling literature,26 where it is used to adjust for unequal sampling fractions – typically the oversampling of certain smaller
but important subgroups in a population. When the weights are extreme, they may be truncated or normalised.27
As before, the PS is usually estimated via a parametric model. So, similarly to previously described estimation steps, the IPW
estimation procedure is straightforward and consists of:
1. Fitting the PS model: e.g. logistic regression model for the probability of being treated.
2. Calculating the weights:
(a) Use the fitted PS to predict the probability that a person received the treatment s/he did in fact receive.
(b) Set each individual’s weight to one over the probability computed in (2a). “Stabilize" this weight by including the
simple probability of being treated in the numerator. Optionally: truncate weights or normalize weights.
(c) Check the confounders’ balance in the weighted sample. If balance is inadequate, return to step 1.
3. Fitting the outcome model: weighting each individual by the weights computed in (2b), fit a regression model for the
outcome given the treatment. The treatment coe cient is an estimate of the ATE.
Following the estimation procedure above, standard errors must be computed analytically or via bootstrap to account for esti-
mation of the weights. Robust or empirical standard errors provide reasonable coverage, although they do not explicitly account
for the fitting of the PS model.
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To estimate the ATT, rather than the ATE, we change our focus toE[Ya(1)*Ya(0)A = 1]. Clearly, we can compute an estimate
of E[Ya(1)A = 1] with little trouble, as this is easily identified and estimated in the data by
öE[Ya(1)A = 1] = (#IA=1)*1 …
iÀIA=1
aiyi.
The second term, E[Ya(0)A = 1], requires a bit more work: this is an average of the potential outcome Yi,a(0) in the (impossi-
ble) situation where the i indexes those who were in fact treated. It turns out that we can again use reweighting of the observed
sample of the untreated individuals by
öE[Ya(0)A = 1]] = n*1 n…
i=1
wATTi (1 * ai)yi, (4)
with stabilized weights equal to
wATTi =
ÇP (Ai = 1Li)
ÇP (Ai = 0Li) ù
ÇP (Ai = 0)
ÇP (Ai = 1)
.
As before, the weighting has been used to construct a pseudo-population in which there are no imbalances on measured
covariates between the exposure groups. In the case of the ATT, we do so by re-balancing the distribution of the covariates in
the unexposed group only.
Care must be taken as, in practice, a small number of large weights can be highly influential, though this may be mitigated
through ad-hoc e ective solutions such as shrinking of the largest weights to a smaller value such as the 99th percentile of the
weight distribution (often referred to as truncation).
4.1.4 A hybrid approach: doubly robust estimation
Inverse probability of treatment weighted estimators can also be augmented. Note that
E[Ya(a)] = E[Ya(a) *  a(a)(L)] + E[ a(a)(L)]
where here,  a(a)(L) is the expected outcome withA set to a and covariates taking valuesL. Invoking the consistency and NUC
assumptions, we have  a(a)(L) = E[Y A = a,L = l] which is, in practice, replaced by a parametric model. This gives rise to
the alternative estimator
öE[Ya(a)] =
1
n
n…
i=1
I[Ai = a](yi * Ç (a(a), li))
ÇP (Ai = aL = li) + 1n
n…
i=1
Ç (a(a), li), (5)
with I[ ] the indicator function that takes value 1 when condition   holds and 0 otherwise, and Ç a(l) a model-predicted mean
for Y with A set to a and L as observed. The estimator (5) is doubly robust, which means that it is consistent even if one of
P (Ai = aL = li) and the modelled mean  a(a)(L) is misspecified. If both models are correctly specified, then the augmented
inverse weighted estimator is at least as e cient as the unaugmented inverse weighted estimator.
Bang & Robins,28 building on Scharfstein et al.,29 reformulated the augmented estimator, noting that it can be viewed as an
unweighted regression that includes the inverse of the propensity score as a covariate. Thus, what first appears to be a somewhat
complicated estimator is in fact very easy to implement. Unlike for the propensity score model, the outcome regression model
in augmented inverse probability weighted estimation can rely on conventional variable selection approaches.
4.2 Instrumental variable based methods
All methods described so far yield valid estimates under the NUC assumption. This assumption is easily violated in observational
studies, where the prognosis of patients tends to determine the choice of treatment and the reasons for a specific treatment choice
are seldom completely registered or, more generally, the exposure level is influenced by unmeasured factors. One alternative
approach is instrumental variable (IV) analysis which can handle both measured and unmeasured confounding. Unbiased estima-
tion results once a ‘pseudo random variable’ or so called ‘instrumental variable’ is identified and some additional assumptions
hold. The method originates from econometrics30,31 and is becoming increasingly popular in medical research. The literature
on IV, with examples, is vast.32, 33, 34, 35, 36 We will discuss here the general IV assumptions, typical causal estimands, and the
corresponding estimation procedures that are most commonly used. To focus on the principles here, our formalization below
ignores the measured baseline covariates L, although the approach extends quite naturally to conditioning on them.
An IV analysis aims to resemble that of a RCT, by using one or more variables (instruments) associated with treatment, but
not in any other way related to the outcome. The instrument can be seen as a surrogate for randomisation. This is depicted in
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Figure 2 whereZ, the instrumental variable, is associated with A (the Figure suggests a causal relation but that is not necessary,
association is su cient). The instrumentZ is related to response Y only via the treatment A; and the instrument is independent
of unmeasured confounders U .
Instrumental variable analysis can be used in trials to study the e ect of non compliance,30,37, 38 as in our BEP example,
where randomisation to the o er of the breastfeeding programme could be used as instrument for attending the programme.
Variation in preference for a certain treatment among physicians39,40 or variation in treatment policies among medical centers41
are other examples of variables which can be considered close to pseudo-randomization for treatment or policy assignment.
When physicians have strong preferences for one or another treatment, identical patients may receive di erent treatments; a
variable measuring the physician’s preference, like the percentage of prescriptions A = 1 in a certain time window, could be
used here as an instrument. Another popular IV approach is found in so called ‘Mendelian randomisation’ studies where genetic
variation takes the role of the instrumental variable.42,43
4.2.1 The three core IV assumptions
To be an instrumental variable for the causal e ect of A on Y , Z should satisfy the following three core assumptions (possibly
conditional on L):
IV1 Z is associated with the treatment A of interest;
IV2 Z is independent of any unmeasured confounders of the Aô Y relationship;
IV3 Z is independent of the outcome Y conditional on treatment A and unmeasured confounders U .
Unfortunately only assumption IV1 can be empirically checked in the data.44 Assumptions IV2 and IV3 are not verifiable in
the data: only their plausibility can be examined. For example the observation thatZ is independent of all observed confounders,
makes assumption IV2 more plausible. Situations in which these assumptions are likely or unlikely to hold are discussed for
Mendelian randomisation and for physician’s preference by several authors.42,43, 32 AssumingZ is an IV and that no interference,
consistency and positivity hold, IV-based estimation does not require the NUC assumption to lead to an estimator. However, an
IV estimator on its own can only provide bounds for causal treatment e ect.45,46 These bounds are generally so wide that they
are not useful. In order to obtain point estimates, additional assumptions are needed as discussed below.
4.2.2 Standard IV estimation
There are several ways of obtaining point estimates in an IV analysis. The traditional IV estimator is theWald estimator,47 which
dates back to Write’s publication in 1928,48 and equals:
Ç IV =
ùcov(Y ,Z)
ùcov(A,Z)
=
≥n
i=1 yizi *
1
n
(≥ni=1 yi)(≥ni=1 zi)≥n
i=1 ziai *
1
n
(≥ni=1 zi)(≥ni=1 ai) .
This estimator is based on two relationships which can be estimated unbiasedly because they are unconfounded: the relation-
ship between instrument Z and outcome Y , and the relationship between instrument Z and treatment A. In case of a binary
instrument, this expression reduces to
Ç IV =
öE[Y Z = 1] * öE[Y Z = 0]
öE[A = 1Z = 1] * öE[A = 1Z = 0] , (6)
where öE[Y Z = z] refers to the simple average of Y in the selected subset with Z = z À {0, 1}. Similarly, öE[AZ = z] is a
simple average of A in the selected subset with Z = z.
The numerator expresses the e ect of instrument on outcome; the mean di erence between those with Z = 1 and Z = 0,
or the risk di erence in the case of a binary outcome. To obtain an estimate of the e ect of the treatment on the outcome, the
e ect of the instrument on the outcome is inflated by dividing the numerator by the e ect of the instrument on the treatment.
The smaller the correlation between Z and A (the so-called strength of the instrument), the larger the inflation factor.
The traditional IV estimator can be equivalently obtained through a two stage linear regression (2SLS) approach. In the first
stage, a linear regression model is fitted with treatmentA as dependent variable and the instrumentZ as an independent variable
(and optionally measured confounders L), yielding for each subject öE[AZ = zi]. In the second stage, a linear regression model
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is fitted to the outcome Y on ÇE[AZ] (and possiblyL). The regression coe cient for ÇE[AZ] is the IV estimate of the treatment
e ect, under assumptions which we will discuss next.
Many authors apply 2SLS methods to binary outcomes by fitting linear regression outcome models and hence yielding esti-
mates of risk di erences. This is not advisable when also including covariatesL as the fitted model may predict outcome values
> 1 or < 0. Extending the two stage approach to a logistic regression outcome model would be hampered by the non linearity of
the logistic model. A two stage approach with a linear model in the first stage and a logistic model in the second stage can only
be used to obtain IV estimates of odds ratios if the outcome is rare. Otherwise, it is preferable to use logistic structural mean
models.49,50, 51
4.2.3 Assumptions needed for a causal e ect interpretation
The three main IV assumptions are not su cient for a causal interpretation of the IV estimator. There are several options for
additional assumptions, which may lead to di erent causal interpretations of the IV estimator.
1. The most strict assumption demands that the e ect of the treatment is the same within levels of U , by assuming that
E[Y A,U ] =  0 +  1A +  2U .37, 49 Then the 2SLS IV estimator consistently estimates the ATE. Assuming the same
treatment e ect for all individuals is, in general, unrealistic as more severely a ected patients may benefit more (or less)
from treatment, the treatment could interact with other drugs, men and women could respond di erently, and so on.
2. Assumptions regarding a homogeneous treatment e ect can be relaxed using structural mean models (SMM).52,49 An
SMM is a model for the mean di erence between an observed outcome Y and a potential outcome such as Ya(0), that may
condition on observed treatment A and instrument Z. A simple SMM is:
E[Y * Ya(0)A,Z] = A 1, (7)
which assumes thatE[Y *Ya(0)A,Z] does not depend onZ. Furthermore forA = 0we haveE[Y *Ya(0)A = 0,Z] = 0,
which is exactly the (mean) consistency assumption for a(0). When A = 1 we obtain E[Y * Ya(0)A = 1,Z] =  1,
and if the consistency assumption holds  1 equals the ATT. Simple unbiased estimating equations can be defined from
this model,37 with solution equal to the Wald estimator. Baseline covariates L could be included in this model, including
interactions between L and exposures A.37
If one additionally assumes ‘no current treatment e ect interaction’, i.e. the structural mean e ect of treatment does not
depend on the observed treatment, then this expression can also be used to calculate the E[Ya(1)L] and hence the ATE.
3. An alternative assumption is monotonicity, which we will explain here for the situation with a binary instrument Z that
causally a ects a binary treatment A. With Az(z) the value of A when Z is set to z À {0, 1}, four types of subjects can be
identified:
(1) always takers: those with Az(1) = Az(0) = 1, i.e. subjects who will use treatment regardless of the value of the
instrument;
(2) never takers: those with Az(1) = Az(0) = 0;
(3) compliers: those with Az(1) = 1 and Az(0) = 0; and
(4) defiers: those with Az(1) = 0 and Az(0) = 1.
Themonotonicity assumption implies that defiers do not exist,30 i.e.Az(1) g Az(0). Under this assumption, the IV estimator
(6) consistently estimates a local causal e ect, i.e. a causal (average) treatment e ect in the subgroup of compliers, or the
Complier Average Causal E ect (CACE):
CACE = E[Ya(1) * Ya(0)Az(1) = 1 and Az(0) = 0)]
The interpretation of the CACE is often di cult,48, 53, 54 because the subgroup of compliers cannot be identified from the
data, although general characteristics like the distribution of age and sex can be obtained.55 In some particular instances,
however, it could be the parameter of interest: in our BEP example, the CACE represents the e ect of the programme
in the subgroup of individuals for which the programme is acceptable and accepted, e.g. the CACE for A2 is the e ect
among those individuals who will attend the breastfeeding programme when invited but not otherwise. Although this
formulation is appealing, when the instrumental variable is continuous, defining monotonicity is more complicated and
the interpretation often even less intuitive.56,54
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4.2.4 When are IV methods useful?
We have discussed the IV assumptions needed to estimate causal treatment e ects. Although many IV estimators are consistent,
in finite samples instrumental variable estimators are generally biased. The bias depends on the sample size and on the strength
of the instrument (i.e the correlation betweenZ andA).57 Furthermore, IV estimates are very sensitive to deviations from the IV
assumptions. A small association between the unmeasured confounders and the instrument can lead to substantial bias especially
if the instrument is weak.57,58 Moreover, weak instruments yield very imprecise IV estimates and often (very) large sample sizes
are needed to obtain informative results.59 This implies that instruments should be strongly correlated to the treatment. There is
however a trade-o  between the amount of unmeasured confounding and the strength of the instrument: an instrument cannot
be strong if there is substantial unmeasured confounding58 and a strong instrument implies weak unmeasured confounding.
To summarize, an instrumental variable analysis may be useful in the following situations: (1) the amount of expected unmea-
sured confounding is substantial, (2) an instrument exists for which the core IV assumptions are plausible and additionally a
fourth assumption to interpret the point estimate can be sensibly invoked, (3) the instrument is su ciently strong, and (4) sample
sizes are su ciently large (when instruments are weak, required sizes may be in the order of several thousands of subjects). Oth-
erwise methods assuming NUC should be considered, while also maximizing the number of measured confounders. Although
approaches relying on NUC yield biased estimators if unmeasured confounding is present, the direction of the bias is often
known and the size of the bias may be approximated in sensitivity analyses.
4.3 Choosing an estimation method
Table 3 reviews several points that go to the heart of which causal estimands are meaningful and relevant in the specific setting
represented by our case study. An accompanying Table 4 summarises the main assumptions that are invoked by the various
methods reviewed in this section when aiming to estimate the ATE (in addition to no interference and causal consistency). The
Table is self-explanatory and highlights that the core di erence lies in whether we are prepared or not to assume NUC, given a
vector of measured confounders L. However it is worth stressing these additional points.
For those methods assuming NUC:
• Outcome regression assumes a correct specification of the outcome model
• PS-matching and PS stratification assume that the PS balances the confounder distribution
• IPW assumes that the PS model is correctly specified given a su cient set of confounders.
• Linear outcome regression models that condition on the estimated PS, as opposed to the original vector of confoundersL,
require that either the outcome model or the PS model is correct and that the treatment e ect does not vary with the PS.60
• The specification of the PS model should achieve balancing of the distribution of the measured confounders across treat-
ment arms. Achieving this aim is substantially di erent from achieving treatment prediction, and hence the criteria used
for the latter do not apply here.
• In general, outcome regression is more e cient than a PS-based method.
• The choice between PS-based methods (i.e. stratifying, regression adjustment, matching and IPW) depends on whether
e ciency is an issue. Weighting may be ine cient (unless a doubly robust approach is used) if there are subjects with a
very high or low PS value; matching has a trade o  between a close match (which implies loss of e ciency because not
all subjects are matched) versus residual confounding.
When not assuming NUC
• IV estimation replaces the NUC assumption with other rather stringent assumptions.
• IV methods yield estimates that are very ine cient when instruments are weak and su er from small sample bias.57
With any given approach come choices in implementation that imply a trade-o  between bias and variance. For example,
in the context of PS matching, the use of smaller calipers to determine a match will reduce bias but may lead to a smaller
matched sample and hence loss in e ciency. In PS-inverse weighting, the use of weight truncation to reduce the influence of a
small number of points has the e ect of decreasing the variance at the cost of introducing some bias. It is hence impossible to
recommend a single “best” approach, but rather choices are specific to the context where researchers must balance bias, statistical
e ciency, and in some cases computational e ciency.
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5 RESULTS FROM THE SIMULATION LEARNER
We applied the methods discussed in the previous section to estimate the ATE and the ATT of A1, A2 and A3 on weight at 3
months using the data from the simulation learner PROBITsim. More details and the code used to produce the reported results
are given in Appendix 2 and in the material available at www.ofcaus.org.
5.1 E ect of the randomized programme o er (A1)
First we estimate the causal e ect of the randomized o er of the BFE (A1) on weight at 3 months. This is simply the di erence
in mean weight at 3 months between those with A1 = 1 and A1 = 0 because A1 is randomized. This is also an estimate of
the intention-to-treat (ITT) e ect, in this case an “intention to educate”, and is most relevant for health policy makers. This
estimate is 94.2 grams (95% confidence interval: 76.4 to 112.0 grams). It indicates that inviting all expecting mothers in the
study population to attend this specific programme would increase their baby’s weight by 94 grams, on average. The true value
obtained from Table 2 was 98 grams and is well within the confidence interval.
5.2 E ect of programme uptake (A2)
Table 5 shows the estimated ATE for A2, which is the e ect most directly relevant to women deciding whether or not to attend
the programme if o ered.We also show the corresponding estimatedATT. In Section 3we showed that the true ATE2 was greater
than ATT2 (165.1 vs. 152.8 grams), whereby the treated, i.e. the mothers who attended the programme, were on average, more
educated and their infants had higher weight at 3 months but smaller increases from attending the programme. We estimated
these target parameters under di erent assumptions and model specifications, starting from crude estimates where confounding
is ignored (£ATE2=196.0 grams and£ATT2=148.7 grams). We then controlled for measured confounding via outcome regression,
adopting two alternative model specifications that included all the potential confounders for the A2 to weight at 3 months
relationship: maternal age, education, allergy status, smoking during pregnancy and area of residence. In the first specification
we included a quadratic term for maternal age, and in the second we also included interactions betweenA2 and each confounder.
The first led to£ATE2=155.4 grams and the second to£ATE2=165.0 grams, much closer to the true value of 165.1 grams.
When applying the PS-based methods, we fitted the PS model by logistic regression with the same confounders (including the
quadratic term for maternal age). Stratification (over 6 strata) led to the same estimates as the more general outcome regression
models (£ATE2=165.0 and £ATT2=148.7 grams), while matching, either to 1 or 3 other infants, led to slightly smaller and less
precise, estimates. Balance checks revealed that the PS model was well specified (see Appendix 2). Adopting inverse weighting
or doubly robust estimation gave estimates closer to those from outcome regression, also in terms of precision.
The reported IV estimate used A1 as the instrument and assumed no A1–A2 interaction to be interpreted as an ATE. This was
estimated at 146.2 grams and, as expected, has a very large estimated standard error.
5.3 E ect of starting breastfeeding (A3)
The estimated ATE and ATT for the e ect of A3 on infant weight at 3 months are found in Table 6 . As before they are obtained
under di erent assumptions and using di erent methods. As their true values depend on whether the exposure is set in a world
where the BEP is or not present, results are reported separately under these two scenarios.
Note also that the true average potential outcome in the world where no programme was o ered but all mothers start breast-
feeding was lower than in the world where BEP is o ered to all mothers and they all start breastfeeding (??, rows 8 and 9)
because of the e ect of the BEP on breastfeeding duration. This impacts on the causal e ect of breastfeeding when A1 is set at
0, ATE3,a1(0) = 386.8 grams and ATT3,a1(0) = 380.1 grams; when A1 set to 1, ATE3,a1(1) = 422.3 grams and ATT3,a1(1) = 421.4grams.
The confounders of theA3 to weight at 3 months relationship include not only maternal age, education, allergy status, smoking
during pregnancy and area of residence (i.e. those involved in the analyses ofA2), but also the infant’s sex, birth weight (including
a quadratic term) and whether the infant was born by caesarian section. In the analyses concerning the world where A1 is set to
be 1, A2 is also a confounder as it influences both A3 and infant weight.
There is little di erence across the ATE estimates, obtained using either outcome regression or PS-based methods: the results
are all very similar and standard errors, while variable, all still lead to the conclusion that A3 meaningfully and statistically
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a ects the outcome. Balance checks for these two scenarios revealed that the PS model was relatively well specified in both,
although there was greater separation (less overlap) than for PS-model for A2 (see Appendix 2).
We do not produce an equivalent IV estimate as there is no suitable IV for this e ect, since A1 violates the second IV
assumption: A1 influences the outcome not only via A3 but also via A2.
For the ATT estimates, regression adjustment seems to perform better than the other methods, especially in the world where
A1 = 1. Of course, our simulation learner has generated just one relatively simple world model where both our outcome and
propensity model are easy to specify.
6 DISCUSSION
We set out to discuss ‘the making of’ a causal e ect question involving a well-defined point exposure for which we seek to find
the average treatment e ect, possibly conditional on baseline characteristics. We have maintained an emphasis on the framing
of the scientific causal question, and in considering many methods together, in their basic form, so as to compare and contrast
the required assumptions of di erent principled estimation approaches for directly targeted estimands.
We applied the concept of principled estimation in turn to four di erent options for exposure levels which present themselves
along the path from treatment prescription to completion. As we moved with the selected exposure along this path, the su cient
set of baseline confounders (and e ect modifiers) became richer, and we had to account for what happened earlier in the path.
In doing so, we saw that we cannot treat randomization as ‘once an instrument, always an instrument’. Rather, randomization
(our A1) may act as an instrument for the e ect of following the programme (A2), but it violated the assumptions required for it
to be an instrument when studying the e ect of ‘starting breastfeeding’ (A3). At every instance, thought is required to adapt to
the new situation and estimate a relevant causal e ect in a (sub)population of interest.
In a similar vein, confounders that act as e ect modifiers could be conditioned on to estimate average causal e ects within
specific population strata. Subsequently, we can average over their distribution in the population of interest. With additional
averaging, we lose some ability to o er stratified evidence and provide personalized information but uphold a more global public
health perspective. This pertains to both the ATE and ATT target.
For selected estimands, we showed how the various estimating approaches perform in their most basic form. We recognized
that many of them operate under similar identifying assumptions. For example the di erent propensity methods all assume
correct specification of the PS model, and when choosing one of the methods one should consider additional issues. For the
stratification, the choice of the number of strata and residual bias, for the matching the trade of between finding matched individ-
uals and the fineness of the matching, and for the inverse probability weighting, the size of the weights, truncation. Of course,
di erences remain in operating characteristics when key (untestable) assumptions are violated. The list of available approaches
under the NUC assumption includes familiar standardized means derived from the classic regression of outcome on baseline
covariates and the exposure. This need not perform worse, and can even be better than more novel PS-based methods that seek
covariate balance after using the propensity score for regression, matching, stratification or inverse probability weighting. Dou-
bly robust methods may be expected to outperform others when one set of model assumptions is violated, but equally loses
precision (increases error) when both the outcome regression and PSmodel are ill-fitting, and may be ine cient in finite samples
when only one model is correctly specified.61
When we cannot find a su cient set of confounders, instrumental variable approaches form an appealing alternative provided
an instrument can be found. To interpret the resulting estimator additional assumptions are needed that are not always easy to
justify; whether those can lead to very broad confidence intervals. There are other alternative routes still, such as regression
discontinuity designs for instance,62 a variation on pseudo-randomization that is found in specific designs.
We set out to give an overview of the basic principles that guide causal inference however in practice, many complications
conspire to challenge the applied statistician when performing causal inference. We, for instance, have implicitly assumed all
covariates are measured without error and there is no selection bias or drop-out. In practice, data may be not just confounded,
but may also su er from missingness28 and measurement error on exposure63 or confounders64 is likely. Flexible models may
be more appropriate to capture the associations involved. Clustering and no-interference may require extension of the presented
set-up to incorporate interference.65,12, 66 With substantial dropout from a longitudinal outcome due to mortality, one must adapt
the definition of the outcome explicitly or reduce the target population to potential survivors on all treatments considered.67
In the international initiative of Strengthening Analytical Thinking for Observational Studies (STRATOS)68 other topic groups
focus on guidance for these topics and joint developments with our causal inference topic group are envisaged for the future.
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We have purposefully focused on the point (i.e. fixed) exposure perspective, even though we considered a natural sequence of
exposures. This allowed us to present an overview of di erent estimation principles, showing how they resemble one another,
and where and how they di er in their fundamental assumptions and performance. The natural next step is to consider the
joint e ect of a sequence of exposure options a2, a3, a4 as a time-varying treatment regime and engage in estimating causal
e ects of di erent (static or dynamic) treatment strategies. To achieve this, we would need to formally account for time-varying
confounders along that path (see, for example69,70). We might further aim to explain the total e ect and engage in mediation
analysis to evaluate the possible role of intermediate variables on the causal path.71,60, 72 For all these endeavours in higher
dimensions, the principles laid out here continue to form an important foundation.
Even at the point exposure level, the literature on adaptations of these estimators under additional or alternative assumptions
is vast, but beyond the scope of this tutorial. Here, we focused on a binary exposure and a continuous, uncensored outcome.
When exposures are categorical or continuous, a generalized propensity score can be used.73,74
In the course material that accompanies this paper, practical exercises discuss estimation when the primary outcome is binary,
using the Right Heart Catheterisation dataset.75 Estimating a linear e ect, a risk di erence, is less obvious there and requires
extra care.
We hope the lay-out of this principled approach will inspire practising statisticians to think carefully about what they are
estimating and to report as clearly as possible on the nature of their exposure and causal estimand, as well as the assumptions
on which they have relied. A naive analysis can be dangerous when followed by either implicit or explicit causal claims that are
made without regard for confounding or e ect modification or for their population level interpretation.We hope this contribution
can generate confidence and insight into methodological ground-rules, and promote better thinking, reliable estimates and clear
reporting.
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TABLE 1 A selection of causal estimands for exposures A1 and A2
Estimand Definition
E ect of Programme O er (a1)
ATE1=ATT< Average Treatment E ect
E[Ya1(1)] * E[Ya1(0)]
E ect of Programme Uptake (a2)
ATE2 Average Treatment E ect
E[Ya2(1)] * E[Ya2(0)]
ATT2 Average Treatment e ect among the Treated†
E[(Ya2(1)A2 = 1,A1 = 1] * E[Ya2(0)A2 = 1,A1 = 1]
ATNT2 Average Treatment e ect among the Non-Treated†
E[Ya2(1)A2 = 0,A1 = 1] * E[Ya2(0)A2 = 0,A1 = 1]
< Intention to treat
† Note that the ATT and ATNT for a2 can only be derived from the (random) subgroup A1 = 1 since the
the programme is only available within the randomized trial and to those assigned to it being o ered.
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TABLE 2 True average potential infant weight at 3 months under di erent interventions in di erent (sub)populations.
Potential A1 = 1 A1 = 1 A1 = 1 A1 = 0 A1 = 0 Educationoutcome Interventions overall A2 = 1 A2 = 0 A3 = 1 A3 = 0 A3 = 1 A3 = 0 low int high
Ya1(0) BEP not o ered 6017 6047 5964 6149 5733 6274 5761 5914 6057 6141
Ya1(1) BEP o ered 6115 6200 5964 6292 5733 6308 5923 6024 6155 6207
Ya2(0) BEP not followed 6017 6047 5964 6149 5733 6274 5761 5914 6057 6141
Ya2(1) BEP followed 6182 6200 6149 6308 5911 6329 6035 6128 6208 6226
Ya1(0),a3(0)
Ya1(1),a3(0) no BF 5827 5849 5788 5871 5733 5893 5761 5730 5854 5981
Ya2(0),a3(0)
Ya1(0),a3(1) BEP not o ered, BF started 6214 6226 6193 6251 6133 6274 6153 6154 6248 6246
Ya1(1),a3(1) BEP o ered, BF started 6249 6282 6193 6292 6157 6308 6191 6207 6276 6262
Ya2(1),a3(1) BEP followed, BF started 6277 6282 6270 6308 6212 6329 6225 6261 6292 6266
Ya4(1) duration BF = 3 month 6351 6345 6362 6372 6307 6392 6311 6393 6339 6286
BEP: Breastfeeding encouragement programme; BF: breastfeeding; int: intermediate
A2 = 1:women who followed the breastfeeding programme
A2 = 0 and A1 = 1: women who were o ered the breastfeeding programme but did not follow it
A3 = 1 and A1 = 1: women who started breastfeeding in the intervention group
A3 = 1 and A1 = 0: women who started breastfeeding in the control group
A3 = 0 and A1 = 1: women who did not start breastfeeding in the intervention group
A3 = 0 and A1 = 0: women who did not start breastfeeding in the control group
Ya1(0): the potential outcome that would occur if A1 were set to take the value 1. Similar for Ya1(1), Ya2(1), Ya3(0)Ya4(1)
Ya1(0),a3(1): The potential outcome under a double intervention with A1 set to 0 and A3 set to 1. Similar for Ya1(1),a3(1), Ya2(1),a3(1)
Results for Ya1(0) and Ya2(0) are equal, because BEP only a ects the outcome if the programme is followed.
Results for Ya1(0),a3(0), Ya1(1),a3(0), Ya2(1),a3(0) are equal because BEP only a ects Y via A3 and duration of breastfeeding, if started
The e ect of three full months of breastfeeding is not a ected by BEP.
TABLE 3 Considerations for the ATE for exposures A1,...,A4; the same issues arise in estimation of the ATT and ATNT. ITT
= Intention-to-treat.
Exposure Estimand Comments
A1 ITT e ect Randomization ensures unbiased estimation using simple contrasts.
A3 ATEA1 = 1, or
ATEA1 = 0 E ect of starting breastfeeding in a world where all (or no) women areo ered the programme. If we do not condition on A1, then we mix the
two populations (or two “worlds"), which would never co-exist outside
of a trial where only half of women are o ered the intervention. Fur-
ther, A2 is an e ect modifier. Thus, correct specification of the outcome
model requires an A2A3 term, and the ATE must then marginalize over
the distribution of A2. Note that the conditioning on A1 is not relevant
for estimating the causal e ect ofA2, asA1 has the role of an instrument
for A2, but not for A3 or indeed for A4.
A4 ATEA3 = 1 There is no support in the data for an e ect ofA4 in women withA3 = 0.
Note also that A4 = 0 is a mixture of durations of breastfeeding, poten-
tially from 1 day up to just shy of 3 months. The consistency assumption
implies that its estimated e ect refers to settings with the same distri-
bution of breastfeeding discontinuation times. An equivalent statement
holds for the interpretation of A3 = 0 in the row above.
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TABLE 4 Su cient assumptions for estimation methods of the ATE of a binary single point exposure A (assuming throughout
that no interference and consistency hold).
Method Assumptions
NUC Correct specification of Core IV No Z–A int-
Y PS(<) assumpt- eraction
model model ion
Outcome regression
conditional on L ˘ ˘
conditional on PS = e(L) ˘ ˘(<) ˘(<)
Stratification by e(L) ˘ ˘
Matching by e(L) ˘ ˘
IPW by e(L) ˘ ˘
DR via L and e(L) ˘ either or
IV Z ˘ ˘
(<) Either of these if the outcome model is linear.
TABLE 5 Estimated ATE and ATT of A2 on weight at 3 months (in grams) obtained using alternative estimation methods
controlling for relevant confounders<; PROBITsim Study.
Estimand Estimation method Estimate (SE)
ATE True value 165.1Crude regression 196.0 ( 9.6)Regression adjustment (without interactions) 155.4 ( 9.5)Regression adjustment (with interactions) 165.0 ( 9.7)
PS stratification† (6 strata) 165.0 ( 9.4)
Regression with PS † 156.2 ( 9.0)
PS matching (1 match)‡ 155.7 ( 10.1)
PS matching (3 matches)‡ 154.9 ( 10.1)
PS IPW† 164.7 ( 9.3)
PS DR IPW† 164.7 ( 9.7)IV 146.2 ( 14.0)
ATT True value 152.8Regression adjustment (with interactions) 148.7 ( 9.4)
PS stratification† (6 strata) 148.7 ( 9.6)
PS matching (1 match)‡ 145.8 ( 9.8)
PS matching (3 matches)‡ 145.4 ( 9.7)
PS IPW† 148.0 ( 9.6)
< The variables controlled for in each of these analyses were: maternal age (linear and quadratic term), maternal education, maternal allergystatus, smoking status in the first trimester (i.e. before programme allocation), and area of residence.
† SE estimated by bootstrap with 1,000 replications.
‡ SE estimated according to Abadie and Imbens (2012), assuming that the conditional outcome variance is homoscedastic, i.e. does not varywith the covariates or treatment. This is implemented in Stata with the option . This assumption can be relaxed using the optionfor the 1 match analysis and for the 3 matches analysis.
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TABLE 6 Estimated ATE and ATT of A3 on weight at 3 months (in grams) obtained using alternative estimation methods
controlling for relevant confounders< and stratified by whether mothers were o ered the BFE programme; PROBITsim Study.
A1 = 0 A1 = 1Estimand Estimation method Estimate (SE) Estimate (SE)
ATE True value 386.8 422.3Crude regression 503.2 ( 11.6) 582.0 ( 12.2)Regression adjustment (without interactions) 384.3 ( 2.8) 428.0 ( 3.3)Regression adjustment (with interactions) 384.7 ( 3.2) 425.3 ( 2.7)
Regression with PS † 384.4 ( 3.2) 425.9 ( 3.3)
PS stratification† (6 strata) 392.2 ( 4.1) 442.0 ( 6.5)
PS matching (1 match)‡ 386.5 ( 13.7) 429.0 ( 17.4)
PS matching (3 matches)‡ 380.7 ( 12.4) 437.2 ( 15.2)
PS IPW† 384.7 ( 3.8) 426.6 ( 7.1)
PS DR IPW† 384.8 ( 4.0) 426.7 ( 7.3)
ATT True value 380.1 421.4Regression adjustment (with interactions) 378.0 ( 2.9) 421.7 ( 2.5)
PS stratification† (6 strata) 388.8 ( 4.8) 438.3 ( 9.5)
PS matching (1 match)‡ 384.3 ( 15.8) 435.6 ( 21.2)
PS matching (3 matches)‡ 387.9 ( 13.5) 441.2 ( 18.0)
PS IPW† 381.9 ( 5.3) 429.2 ( 10.1)
< The variables controlled for in each of these analyses were: maternal age (linear and quadratic term), maternal education, maternal allergy
status, smoking status in the first trimester (i.e. before programme allocation), area of residence, baby’s birth weight (linear and quadratic
term), whether birth was by caesarian section and, in the analyses restricted to A1 = 1, whether the mother attended the programme.
† SE estimated by bootstrap with 1,000 replications.
‡ SE estimated according to Abadie and Imbens (2012), assuming that the conditional outcome variance is homoskedastic, i.e. does not vary
with the covariates or treatment. This is implemented in Stata with the option . This assumption can be relaxed using the option
for the 1 match analysis and for the 3 matches analysis.
